Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
oxaliplatin;irinotecan;leucovorin;5-fluorouracil;capecitabine;S-1
Sponsor
Chinese Academy of Medical Sciences
Collaborators
[object Object]